Companies /Healthcare
Cardinal Health Inc
NYSE: CAH Medical Distribution
$271.72
▲ $3.90 (+1.46%) today
Markets closed · 6:37pm ET

Cardinal Health (CAH) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
86%
EPS beat rate
+11.14%
Avg. EPS surprise
Consecutive EPS beats
CAH vs Market · 30-day return after each reportCAHS&P 500
−4%0%+4%+8%+6.8%+6.7%Q3 25+4.1%+2.3%Q4 25+8.1%+0.3%Q1 26−4.5%−0.1%Q2 26+1.0%+5.7%Q3 26−2.4%−0.8%Q4 26
−4%0%+4%+8%Q3 25Q1 26Q3 26
CAH EPS Trend · estimate vs actualEstimateActual
$0.00$0.90$1.80$2.70$2.15$2.35Q3 25$2.18$2.08Q4 25$2.17$2.55Q1 26$2.37$2.63Q2 26$2.79$3.17Q3 26$2.42$2.91Q4 26$2.94$3.26Q1 27
$0.00$0.90$1.80$2.70Q3 25Q1 26Q3 26Q1 27
CAH Revenue Trend · estimate vs actualEstimateActual
$0$20.0B$40.0B$60.0B$55.3B$54.9BQ3 25$59.4B$60.2BQ4 25$59.3B$64.0BQ1 26$65.2B$65.6BQ2 26$62.3B$60.9BQ3 26$65.1B$63.7BQ4 26$66.5B$67.5BQ1 27
$0$20.0B$40.0B$60.0BQ3 25Q1 26Q3 26Q1 27

How Often Does Cardinal Health Beat Earnings Estimates?

Cardinal Health beat EPS estimates in 6 of its last 7 reported quarters, and has beaten 5 quarters in a row.

CAH quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q1 2027 Non-GAAP EPS excludes amortization and other acquisition-related costs of $182 million ($0.57/share), acquisition-related cash and share-based compensation costs of $94 million ($0.38/share), restructuring of $23 million ($0.07/share), and a $47 million litigation recovery ($(0.13)/share); GAAP diluted EPS was $2.38 $3.26 est. $2.94 +10.91% $67.5B est. $66.5B +1.51%
Q4 2026 Includes a one-time positive impact of $0.31 per share from recognition of IEEPA tariff refunds ($100 million pre-tax net operating profit impact in the GMPD segment) $2.91 est. $2.42 +20.22% $63.7B est. $65.1B −2.20%
Q3 2026 $3.17 est. $2.79 +13.70% $60.9B est. $62.3B −2.19%
Q2 2026 $2.63 est. $2.37 +11.17% $65.6B est. $65.2B +0.60%
Q1 2026 $2.55 est. $2.17 +17.33% $64.0B est. $59.3B +8.00%
Q4 2025 $2.08 est. $2.18 −4.70% $60.2B est. $59.4B +1.26%
Q3 2025 $2.35 est. $2.15 +9.36% $54.9B est. $55.3B −0.78%

Figures from SEC filings and company reports. Not investment advice.